Literature DB >> 18569478

Does preoperative urodynamics change the management of prolapse?

S Jha1, P Toozs-Hobson, M Parsons, F Gull.   

Abstract

The objective of this study was to evaluate whether preoperative urodynamics (UDS) changed the management of patients undergoing prolapse surgery, and if so in what way. A retrospective study of 72 randomly selected cases was conducted. We assessed which women undergoing prolapse surgery were more likely to undergo UDS and in what way UDS altered management. SPSS version 13 was used to analyse the data. A total of 60% (43/72) of the patients underwent preoperative UDS and 53% (23/43) of the women undergoing UDS had an abnormal result with prolapse reduction; 19% (8/43) had pure urodynamic stress incontinence; 30% (13/43) had detrusor overactivity either in isolation or as mixed incontinence. The surgical management was altered in 7% (3/43), who had an additional continence procedure performed as a consequence of the UDS. Preoperative UDS changed management in 33% (14/43) patients and in 7% (3/43 undergoing UDS) of patients, the surgical procedure was changed.

Entities:  

Mesh:

Year:  2008        PMID: 18569478     DOI: 10.1080/01443610802044825

Source DB:  PubMed          Journal:  J Obstet Gynaecol        ISSN: 0144-3615            Impact factor:   1.246


  3 in total

1.  De-implementation of urodynamics in The Netherlands after the VALUE/VUSIS-2 results: a nationwide survey.

Authors:  Bianca B Mengerink; Willianne L D M Nelen; Sanne A L van Leijsen; John P F A Heesakkers; Kirsten B L Kluivers; Debjyoti Karmakar
Journal:  Int Urogynecol J       Date:  2018-05-03       Impact factor: 2.894

Review 2.  When are urodynamics indicated in patients with stress urinary incontinence?

Authors:  Benjamin E Dillon; Philippe E Zimmern
Journal:  Curr Urol Rep       Date:  2012-10       Impact factor: 3.092

3.  Incontinence and detrusor dysfunction associated with pelvic organ prolapse: clinical value of preoperative urodynamic evaluation.

Authors:  Isao Araki; Yaburu Haneda; Yuki Mikami; Masayuki Takeda
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2009-07-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.